Nina Muro

Ms. Nina Muro


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
Lihua WangLihua Wang
Lihua Wang
YLYuzhen Li
Yuzhen Li
XZXirui Zhang
Xirui Zhang
RMRachel Madera
Rachel Madera
HPHomer Pantua
Homer Pantua
JSJishu Shi
Jishu Shi
African swine fever (ASF), a highly contagious and lethal viral disease, continues to devastate the global swine industry. The emergence of ASF virus (ASFV) variants with varying genomic deletions poses significant challenges for ASF control. This study presents a novel, sensitive, and reliable quadplex real-time PCR assay for detecting ASFV variants lacking key genes (I177L, EP402R, and MGF360-14L), either individually or in combination. The assay targets conserved regions within these genes, ensuring broad coverage of diverse ASFV genotypes. A porcine beta-actin (ACTB) internal control was incorporated to minimize false-negative results. Optimization and evaluation using spike-in tests demonstrated high sensitivity, with a limit of detection (LOD) ranging from 1 to 10 plasmid copies or 0.1 TCID50 of ASFV isolates per reaction. No cross-reactivity was observed when testing serum samples from pigs infected with other common swine viruses. Further validation across a diverse panel of samples, including those from naturally ASFV-infected field pigs (n = 54), experimentally ASFV-infected pigs (n = 50), PBS-inoculated pigs (n = 50), ASFV-free field pigs (n = 100), and feral pigs (n = 6), confirmed 100% specificity. This robust assay provides a valuable tool for rapid and accurate ASF surveillance and control efforts, facilitating the timely detection and mitigation of outbreaks caused by emerging ASFV variants.

1 November 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
XZXirui Zhang
Xirui Zhang
DLDanqin Li
Danqin Li
MAMichael D Apley
Michael D Apley
LKLocke Anderson Karriker
Locke Anderson Karriker
JCJoseph F Connor
Joseph F Connor
JSJishu Shi
Jishu Shi
Antimicrobial resistance (AMR) is a significant global health concern, and the use of antibiotics in livestock, including swine production, is a major contributor. Vaccines offer a promising alternative for controlling bacterial infections in pigs, but their widespread use is often hindered by biological, economic, and practical challenges. This study surveyed U.S. swine veterinarians to identify which bacterial diseases require better vaccines and to understand the barriers to their adoption. Nineteen veterinarians with an average of 24.7 years of experience were surveyed across 21 states. The results identified Streptococcus suis, Escherichia coli, Mycoplasma hyopneumoniae, and Glaesserella parasuis as the most critical pathogens needing improved vaccines. Veterinarians anticipated significant improvements in vaccine efficacy for S. suis and E. coli during the nursery stage and expressed a willingness to pay 1.8 and 1.9 times their current prices, respectively. While expectations for M. hyo vaccine improvements were not significant, veterinarians expressed the highest willingness to pay (4.2 times the current price), citing the potential for disease eradication. This research highlights that developing effective vaccines for S. suis and E. coli should be the most urgent priority due to their significant economic impact and rising AMR concerns. However, M. hyo vaccine development holds the most economic potential due to the possibility of eradication. Our research provides a roadmap for future efforts to combat AMR in the swine industry, emphasizing key economic, policy, and educational considerations for successful vaccine implementation.

6 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
XZXirui Zhang
Xirui Zhang
DLDanqin Li
Danqin Li
MAMichael D Apley
Michael D Apley
LKLocke Anderson Karriker
Locke Anderson Karriker
JCJoseph F Connor
Joseph F Connor
JSJishu Shi
Jishu Shi
Antimicrobial resistance (AMR) is a significant global health concern, and the use of antibiotics in livestock, including swine production, is a major contributor. Vaccines offer a promising alternative for controlling bacterial infections in pigs, but their widespread use is often hindered by biological, economic, and practical challenges. This study surveyed U.S. swine veterinarians to identify which bacterial diseases re-quire better vaccines and to understand the barriers to their adoption. Nineteen vet-erinarians with an average of 24.7 years of experience were surveyed across 21 states. The results identified Streptococcus suis, Escherichia coli, Mycoplasma hyopneumoniae, and Glaesserella parasuis as the most critical pathogens needing improved vaccines. Veter-inarians anticipated significant improvements in vaccine efficacy for S. suis and E. coli during the nursery stage and expressed a willingness to pay 1.8 and 1.9 times their current prices, respectively. While expectations for M. hyo vaccine improvements were not significant, veterinarians expressed the highest willingness to pay (4.2 times the current price), citing the potential for disease eradication. This research highlights that developing effective vaccines for S. suis and E. coli should be the most urgent priority due to their significant economic impact and rising AMR concerns. However, M. hyo vaccine development holds the most economic potential due to the possibility of erad-ication. Our research provides a roadmap for future efforts to combat AMR in the swine industry, emphasizing key economic, policy, and educational considerations for successful vaccine implementation.

13 February 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Lihua WangLihua Wang
Lihua Wang
YLYuzhen Li
Yuzhen Li
XZXirui Zhang
Xirui Zhang
RMRachel Madera
Rachel Madera
HPHomer Pantua
Homer Pantua
JSJishu Shi
Jishu Shi
African swine fever (ASF), a highly contagious and lethal viral disease, continues to devastate the global swine industry. The emergence of ASF virus (ASFV) variants with varying genomic deletions poses significant challenges to ASF control. This study presents a novel, sensitive, and reliable quadplex real-time PCR assay for detecting ASFV variants lacking key genes (I177L, EP402R, and MGF360-14L), either individually or in combination. The assay targets conserved regions within these genes, ensuring broad coverage of diverse ASFV genotypes. A porcine beta-actin (ACTB) internal control was incorporated to minimize false-negative results. Optimization and evaluation using spike-in tests demonstrated high sensitivity with a limit of detection (LOD) ranging from 1-10 plasmid copies or 0.1 TCID50 of ASFV isolates per reaction. No cross-reactivity was observed when testing serum samples from pigs infected with other common swine viruses. Further validation across a diverse panel of samples, comprising those from naturally ASFV-infected field pigs (n=54), experimentally ASFV-infected pigs (n=50), PBS-inoculated pigs (n=50), ASFV-free field pigs (n=100), and feral pigs (n=6), confirmed 100% specificity. This robust assay provides a valuable tool for rapid and accurate ASF surveillance and control efforts, facilitating the timely detection and mitigation of outbreaks caused by emerging ASFV variants.

9 December 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
DLDanqin Li
Danqin Li
XZXirui Zhang
Xirui Zhang
MAMichael D Apley
Michael D Apley
JGJordan T. Gebhardt
Jordan T. Gebhardt
LKLocke Anderson Karriker
Locke Anderson Karriker
JSJishu Shi
Jishu Shi
Antimicrobial resistance (AMR) is an increasing concern in food animal production. In swine herds, viral infections often lead to secondary bacterial disease and higher antimicrobial use (AMU). This study describes how U.S. swine veterinarians view the role of viral vaccines in reducing this reliance on antimicrobials. We conducted a national survey of swine practitioners and follow-up semi-structured interviews with a subset of respondents. Across participants, porcine reproductive and respiratory syndrome (PRRS), swine influenza (SIV), and rotaviral enteritis were most often named as viral diseases in urgent need of improved vaccines. These diseases cause substantial economic losses and frequently trigger AMU in commercial herds. Veterinarians reported several recurring challenges with current vaccines, including limited cross-protection against field strains, interference from maternally derived antibodies, and short duration of protection. Despite these limitations, most respondents supported vaccination as a key tool to curb AMU and indicated they would accept higher prices for clearly improved products. These findings reveal both a clear need and specific opportunities for future vaccine development to provide broader and more reliable protection, reduce AMU, and help slow the development of AMR.

4 November 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DLDanqin Li
Danqin Li
XZXirui Zhang
Xirui Zhang
MAMichael D Apley
Michael D Apley
JGJordan T. Gebhardt
Jordan T. Gebhardt
LKLocke Anderson Karriker
Locke Anderson Karriker
JSJishu Shi
Jishu Shi
Antimicrobial resistance (AMR) is a growing global threat driven by the overuse of antibiotics, especially in livestock. In the swine industry, viral diseases often lead to secondary bacterial infections, which increases the need for widespread antimicrobial use (AMU). This study explores the views of U.S. swine veterinarians on using viral vaccines as a way to reduce reliance on antimicrobials. Through a combination of surveys and interviews, our findings found an urgent need for better vaccines for por-cine reproductive and respiratory syndrome, swine influenza, and rotaviral enteritis. These swine diseases cause major economic losses and are a primary reason for AMU. Veterinarians identified several challenges with existing vaccines, including poor cross-protection against different strains, safety concerns, and issues with cost and availability. Despite these limitations, the study found that veterinarians are willing to invest more in improved vaccines, highlighting a strong demand for more effective tools to reduce antimicrobial use. This research identifies key opportunities for future vaccine development and veterinary strategies to create more effective approaches that protect both animal and public health.